A61K 38/1732
Lectins
Official title: {Lectins}
A61K38/1732 (Lectins) appears on 58 US grants and 123 published applications in this corpus.
Search patents in A61K- Granted patents
- 58
- Published applications
- 123
- Assignees
- 83
- Inventors
- 206
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 3 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 7 |
| 2011 | 1 | 6 |
| 2012 | 1 | 5 |
| 2013 | 2 | 3 |
| 2014 | 1 | 8 |
| 2015 | 1 | 7 |
| 2016 | 10 | 18 |
| 2017 | 8 | 10 |
| 2018 | 8 | 7 |
| 2019 | 9 | 5 |
| 2020 | 3 | 3 |
| 2021 | 3 | 6 |
| 2022 | 1 | 3 |
| 2023 | 0 | 10 |
| 2024 | 1 | 9 |
| 2025 | 3 | 4 |
| 2026 | 3 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Application of TFF2 protein and IFN-κ protein combination in treatment of a novel coronavirus infection6 Oct 2026US 12,751,996 B2Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- Recombinant proteins, compositions and methods of stabilization thereof25 Aug 2026US 12,714,737 B2Unichem Laboratories Ltd
- Multi-virus anti-infectivity and pro-immunity assembly24 Feb 2026US 12,558,387 B2
- Composition and device for preventing hypoglycemia and use thereof21 Oct 2025US 12,447,133 B2The Governing Council of the University of Toronto
- Pharmaceutical composition, comprising recombinant stabilized galectin 9 protein, for prevention or treatment of rheumatoid arthritis and bone disease21 Oct 2025US 12,448,420 B2Gbiologics Inc.
- Methods for Treating Premature Newborn Infants by Administration of Recombinant Human Surfactant Protein D (rhSP-D)20 Aug 2026US 2026/0240946 A1Airway Therapeutics, Inc.
- Method for treating x-linked retinoschisis30 Apr 2026US 2026/0115323 A1Taipei Veterans General Hospital
- Stabilized formulation comprising recombinant stabilized galectin 9 protein26 Mar 2026US 2026/0083671 A1Gbiologics Inc.
- Pharmaceutical composition, comprising recombinant stabilized galectin 9 protein, for prevention or treatment of rheumatoid arthritis and bone disease15 Jan 2026US 2026/0015394 A1Gbiologics Inc.
- Tumor-intrinsic galectin-3 suppresses melanoma metastasis17 Jul 2025US 2025/0228968 A1The Florida International University Board of Trustees
Most cited
By later US patents
- Methods for treating alopecia35US 6,376,557 B12002
- Compositions comprising E-selectin antagonists and uses therefor16US 9,254,322 B2The University of Queensland · 2016
- Treatment of immunocompromised conditions16US 9,486,497 B2The University of Queensland · 2016
- Ophthalmic compositions and methods for treating eyes13US 8,569,367 B2Allergan, Inc. · 2013
- Method and composition of inducing hair follicle neogenesis6US 9,737,570 B2Academia Sinica · 2017